Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders

Expert Review of Neurotherapeutics

Volumn 7, Issue 1, 2007, Pages 63-74

  George, Mark S ^a   Nahas, Ziad ^a   Borckardt, Jeffrey J ^a   Anderson, Berry ^a   Burns, Carol ^a   Kose, Samet ^a   Short, E Baron ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anticonvulsant; Antidepressant; Brain stimulation; Neuromodulation; Vagus nerve; VNS

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; BRAIN FUNCTION; BREATHING; CLINICAL TRIAL; DRUG TOLERANCE; ELECTROCONVULSIVE THERAPY; ELECTRODE; EPILEPSY; HOARSENESS; HOMEOSTASIS; HUMAN; HUNGER; INTERMETHOD COMPARISON; MAJOR DEPRESSION; MENTAL DISEASE; META ANALYSIS; NEUROPSYCHIATRY; NONHUMAN; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PUBLIC SPEAKING; RADIODIAGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; THORAX PAIN; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VOICE CHANGE;

COGNITION DISORDERS; DEPRESSION; ELECTRIC STIMULATION THERAPY; HUMANS; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGY; VAGUS NERVE;

EID: 33846297338     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.1.63     Document Type: Review

References (99)

1. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51, 8-19 (1994).
2. Doyle JJ, Casciano J, Arikian S et al. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs. Value Health 4(1), 16-31 (2001).
3. Kozel FA, George MS, Simpson KN. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectr. 9(6), 476-482 (2004).
4. Rush AJ, Trivedi MH, Wisniewski SR et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. 354(12), 1231-1242 (2006).
5. Thase ME. Studying new antidepressants: if there were a light at the end of the tunnel, could we see it? J. Clin. Psychiatry 63, 24-28 (2002).
6. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br. J. Psychiatry 178, 234-241. (2001).
7. Thase ME. The need for clinically relevant research on treatment-resistant depression. J. Clin. Psychiatry 62, 221-224 (2001).
8. Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J.Psychiatry 163(1), 28-40 (2006).
9. Thase ME. Treatment of severe depression. J. Clin. Psychiatry 61(Suppl. 1), 17-25 (2000).
10. Miller I, Keitner G, Schatzberg A et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J. Clin. Psychiatry 59, 608-619 (1998).
11. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J. Clin. Psychiatry 58(Suppl. 13), 23-29 (1997).
12. Rush AJ, Thase ME. Strategies and tactics in the treatment of chronic depression. J. Clin.Psychiatry 58(13S), 14-22 (1997).
13. Thase ME, Rush AJ. Treatment-resistant depression. In: Psychopharmacology: The Fourth Generation of Progress Bloom F, Kupfer D (Eds). Raven, New York, NJ, USA. 1081-1098 (1995). ASK AUTHOR
14. Sackeim HA, Prudic J, Devanand DP et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N. Engl. J. Med. 328(12), 839-846 (1993).
15. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol. Psychiatry 55(3), 301-312 (2004).
16. George MS, Belmaker RH. TMS in Clinical Psychiatry American Psychiatric Press, Washington DC, USA (2006).
17. George MS, Nahas Z, Li X et al. Current status of daily repetitive transcranial magnetic stimulation for the treatment of depression. Prim. Psychiatry 12(10), 51-58 (2005).
18. Kozel FA, George MS. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J. Psych. Pract. 8, 270-275 (2002).
19. O'Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial. Biol. Psychiatry (2007) (In Press).
20. George MS. Transcranial magnetic stimulation: a stimulating new method for treating depression, but saddled with the same old problems. Int. J. Neuropsychopharmacol. 9(6), 637-640 (2006).
21. Li X, Nahas Z, Anderson B, Kozel FA, George MS. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress. Anxiety 20(2), 98-100 (2004).
22. O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J. Clin. Psychiatry 66(12), 1524-1528 (2005).
23. Schachter SC, Saper CB. Vagus nerve stimulation. Epilepsia 39(7), 677-686 (1998).
24. Roslin M, Kurian M. The use of electrical stimulation of the vagus nerve to treat morbid obesity. Epilepsy Behav. 2, S11-S16 (2001).
25. Amar AP, Heck CN, Levy ML et al. An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique and outcome. Neurosurgery 43, 1265-1280 (1998).
26. Benazzouz A, Hallett M. Mechanism of action of deep brain stimulation. Neurology 55, S13-S16 (2000).
27. Maniker A, Liu W-C, Marks D, Moser K, Kalnin A. Positioning of vagal nerve stimulators: technical note. Surgical Neurology 53, 178-181 (2000).
28. Bohning DE, Lomarev MP, Denslow S et al. Feasibility of vagus nerve stimulationsynchronized blood oxygenation leveldependent functional MRI. Invest. Radiol. 36, 470-479 (2001).
29. Sackeim HA, Keilp JG, Rush AJ et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol. Behav. Neurol. 14(1), 53-62 (2001).
30. George MS, Belmaker RH. Transcranial Magnetic Stimulation in Neuropsychiatry George MS, Belmaker RH (Eds). American Psychiatric Press, Washington, DC, USA (2000).
31. George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch. Gen. Psychiatry 56, 300-311 (1999).
32. Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 354, 1526 (1999).
33. Mayberg HS, Lozano AM, Voon V et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651-660 (2005).
34. Foley JO, DuBois F. Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory and motor studies. J. Comp. Neurol. 67, 49-67 (1937).
35. Bailey P, Bremer F. A sensory cortical representation of the vagus nerve. J. Neurophysiol. 405-412 (1938).
36. Dell P, Olson R. Projections 'secondaires' mesencephaliques, diencephaliques et amygdaliennesdes afferences viscerales vagales. C. R. Seances Soc. Biol. Fil. 145, 1088-1091 (1951).
37. Maclean PD. The Triune Brain in Evolution: Role in Paleocerebral Functions MacLean PD (Ed.). Plenum Press, New York, NJ, USA (1990).
38. Maclean PD. Culminating Developments in the Evolution of the Limbic System: The Thalamocingulate Division. In: The Limbic System: Functional Organization and Clinical Disorders. Doane BK, Livingston KE (Eds.). Raven Press, New York, NJ, USA (1986).
39. Zabara J. Time course of seizure control to brief, repetitive stimuli. Epilepsia 26, 518 (1985).
40. Zabara J. Peripheral control of hypersynchronous discharge in epilepsy. Electroencephalogr. Clin. Neurophysiol. S61-S62 (1985).
41. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 33, 1005-1012 (1992).
42. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal nerve stimulation in humans: preliminary results. Epilepsy 31, S40-S43 (1990).
43. Uthman BM, Wilder BJ, Penry JK et al. Treatment of epilepsy by stimulation of the vagus nerve. Neurology 43, 1338-1345 (1993).
44. George MS, Sackeim HA, Rush AJ et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47, 287-295 (2000).
45. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology 59(Suppl. 4), S15-S20 (2002).
46. Ter Horst GJ, De Boer P, Luiten PGM, Van Willigen JD. Ascending projection from the solitary tract nucleus to the hypothalamus. a Phaseolus bulgaris lectin tracing study in the rat. Neuroscience 31, 785-797 (1989).
47. Ter Horst GJ, Streetland C. Ascending projections of the solitary tract nucleus. In: Nucleus of the Solitary Tract. Robin I, Barraco A (Eds). CRC Press, London, UK (1994).
48. Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures. Brain Res. 152, 1-10 (1978).
49. Otterson OP. Afferent connection to the amygdaloin complex of the rat with some observations in the cat. III. Afferents from lower brainstem. J. Comp. Neurol. 202, 335 (1981).
50. Zardetto-Smith AM, Gray TS. Organization of peptidergic and catecholaminergic efferents from the nucleus of the solitary tract to the rat amygdala. Brain Res. Bull. 25, 875 (1990).
51. Van der Kooy D, Koda LY, McGinty JF et al. The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in the rat. J. Comp. Neurol. 224, 1-20 (1984).
52. Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure attenuating effects of vagus nerve stimulation. Epilepsia 39, 709-714 (1998).
53. Rutecki P. Anatomical, physiological and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia 31, S1-S36 (1990).
54. Van Bockstaele EJ, Peoples J, Valentino RJ. Anatomic basis for differential regulation of the rostrolateral per-locus coeruleus region by limbic afferents. Biol. Psychiatry 46, 1352-1363 (1999).
55. Naritoku DK, Terry WJ, Helfert RH. Regional induction of Fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 22, 53-62 (1995).
56. Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and Glutamate transmission in nucleus tractus solitarius. Epilepsia 40, 1051-1057 (1999).
57. Nemeroff CB, Mayberg HS, Krahl SE et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31(7), 1345-1355 (2006).
58. Krahl SE, Senanayake SS, Pekary AE, Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J. Psych. Res. 38(3), 237-240 (2004).
59. Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 318(2), 890-898 (2006).
60. Chae JH, Nahas Z, Lomarev M et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J. Psych. Res. 37, 443-455 (2003).
61. Henry TR, Bakay RA, Votaw JR et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39(9), 983-990 (1998).
62. Henry TR, Votaw JR, Pennell PB et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 52, 1166-1173 (1999).
63. Conway CR, Sheline YI, Chibnall JT et al. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res. 146(2), 179-184 (2006).
64. Narayanan JT, Watts R, Haddad N et al. Cerebral activation during vagus nerve stimulation: a functional MRI study. Epilepsia 43(12), 1509-1514 (2002).
65. Lomarev M, Denslow S, Nahas Z et al. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency and/or dose dependent effects at rest and during a simple task. J. Psychiatry Res. 36, 219-227 (2002).
66. Nahas Z, Teneback C, Chae JH et al. Serial vagus nerve stimulation functional MRI (VNS/fMRI) in treatment resistant depression. Neuropsychopharmacology (2007) (In Press).
67. Mayberg HS, Liotti M, Brannan SK et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156(5), 675-682 (1999).
68. Clark KB, Naritoku DK, Smith DC et al. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat. Neurosci. 2, 94-98 (1999).
69. Mu Q, Nahas Z, Bohning DE et al. Interleaved VNS-fMRI is a new method for understanding different VNS use parameters: effects of varying pulse-width in depressed patients. Biol. Psychiatry 53, 213S (603) (2003).
70. Borckardt JJ, Kozel FA, Anderson B et al. Vagus nerve stimulation affects pain perception in depressed adults. Pain Res. Manag. 10(1), 9-14 (2005).
71. Ben-Menachem E, Hamberger A, Hedner T et al. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res. 20, 221-227 (1995).
72. Carpenter LL, Moreno F, Kling MA. Effects of vagus nerve stimulation on cerebrospinal fluid in depressed patients. Biol. Psychiatry 51, S152-S449 (2002).
73. Armitage R, Husain M, Hoffmann R, Rush AJ. The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. J. Psychosom. Res. 54(5), 475-482 (2003).
74. Handforth A, DeGiorgio CM, Schachter SC et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 51, 48-55 (1998).
75. Ben-Menachem E, Manon-Espaillat R, Ristanovic R et al. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. Epilepsia 35, 616-626 (1994).
76. Morris GL, Mueller WM, (E01-E05) VNSSG. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology 53, 1731-1735 (1999).
77. Salinsky MC, Uthman BM, Ristanovic RK et al. Vagus nerve stimulation for the treatment of medically intractable seizures: results of a 1-year open-extension trial. Arch. Neurol. 53, 1176-1180 (1996).
78. George R, Salinsky M, Kuzniecky R et al. Vagus nerve stimulation for treatment of partial seizures: 2. Long-term follow-up on first 67 patients exiting a controlled study. Epilepsia 35, 637-643 (1994).
79. George MS, Sackeim HA, Rush AJ et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47(4), 287-295 (2000).
80. Harden CL, Pulver MC, Ravdin LD et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 1, 93-99 (2000).
81. Elger G, Hoppe C, Falkai P et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 42, 203-210 (2000).
82. Post RM, Ketter TA, Denicoff K et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128(2), 115-129 (1996).
83. Krahl SE, Senanayake SS, Handforth A. Seizure suppression by systemic epinephrine is mediated by the vagus nerve. Epilepsy Res. 38, 171-175 (2000).
84. Sackeim HA, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects and predictors of outcome. Neuropsychopharmacology 25, 713-728 (2001).
85. Marangell LB, Rush AJ, George MS et al. Vagus nerve stimulation (VNS) for major depressive episodes: longer-term outcome. Biol. Psychiatry 51, 280-287 (2002).
86. Nahas Z, Marangell LB, Husain MM et al. Two-year outcome of vagus nerve stimulation (VNS) therapy for major depressive episodes. J. Clin.Psychiatry 66, 1097-1104 (2005).
87. Rush AJ, Marangell LB, Sackeim HA et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatry 58(5), 347-354 (2005).
88. George MS, Rush AJ, Marangell LB et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol. Psychiatry 58(5), 364-373 (2005).
89. Sackeim HA, Brannan SK, Rush AJ et al. Durability of antidepressant response to VNS. Int. J. Neuropsychopharmacol. (2006) (In Press).
90. Charney DS, Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. Arch. Gen. Psychiatry 42, 458-467 (1985).
91. Charney DS, Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Arch. Gen. Psychiatry 42, 473-481 (1985).
92. James W. What is an emotion? Mind 9, 188-205 (1884).
93. Cigaina V. Gastric pacing as a therapy for morbid obesity: preliminary results. Obesity Surgery 12(Suppl. 1), S12-S16 (2002).
94. Ness TJ, Fillingim RB, Randich A, Backensto EM, Faught E. Low intensity vagal nerve stimulation lowers human thermal pain thresholds. Pain 86, 81-85 (2000).
95. Kirchner A, Birklein F, Stefan H, Handwerker HO. Left vagus nerve stimulation suppresses experimentally induced pain. Neurology 55, 1167-1171 (2000).
96. Borckardt JJ, Anderson B, Kozel FA et al. Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase 12(4), 216-220 (2006).
97. Greenberg BD, Price LH, Rauch SL et al. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg. Clin. North Am. 14(2), 199-212 (2003).
98. Greenberg BD, Murphy DL, Rasmussen SA. Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. Psychiatr. Clin. North Am. 23(3), 671-686 (2000).
99. Fallgatter AJ, Ehlis AC, Ringel TM, Herrmann MJ. Age effect on far field potentials from the brain stem after transcutaneous vagus nerve stimulation. Int. J. Psychophysiol. 56(1), 37-43 (2005).